[1]
“Antifibrotics in Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Diseases”, Can Resp Today, vol. 1, no. 3, pp. 17–21, Dec. 2025, doi: 10.58931/crt.2025.1318.